Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 11 Jan 2024

Bibliometric and visual analysis in the field of tea in cancer from 2013 to 2023

in Pharmacology of Anti-Cancer Drugs

Yuanchu Lian
Xiating Li
Ying Lan
Zonghuai Li
Xiaoxin Lin
Jing’an Huang
Bo Zhang
Zhongwen Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1296511

2,211 views
5 citations

Editorial

Published on 04 Jan 2024

Editorial: Metal nanoparticles in cancer: detection, diagnosis, therapy and their pharmacological assessment

in Pharmacology of Anti-Cancer Drugs

Massimiliano Peana
Alexandros G. Georgakilas

Frontiers in Oncology

doi 10.3389/fonc.2023.1344197

1,089 views
3 citations

Original Research

Published on 03 Jan 2024

Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy

in Pharmacology of Anti-Cancer Drugs

Edson Alves de Lima Junior
Alexandre Abilio de Souza Teixeira
Loreana Sanches Silveira
Queralt Jové
Natalia Álvarez Ladrón
Marcelo G. Pereira
Francisco Javier López-Soriano
Josep M. Argilés
Patrícia Chakur Brum
Silvia Busquets

Frontiers in Oncology

doi 10.3389/fonc.2023.1237709

2,206 views
1 citation

Review

Published on 19 Dec 2023

Active components of Solanum nigrum and their antitumor effects: a literature review

in Pharmacology of Anti-Cancer Drugs

Han Zhang
Jun-lin Lv
Qiu-sheng Zheng
Jie Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1329957

5,372 views
6 citations

Review

Published on 13 Dec 2023

Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck

in Pharmacology of Anti-Cancer Drugs

Prashant Puttagunta
Saagar V. Pamulapati
James E. Bates
Jennifer H. Gross
William A. Stokes
Nicole C. Schmitt
Conor Steuer
Yong Teng
Nabil F. Saba

Frontiers in Oncology

doi 10.3389/fonc.2023.1310106

3,627 views
3 citations

Review

Published on 12 Dec 2023

The renal damage and mechanisms relevant to antitumoral drugs

in Pharmacology of Anti-Cancer Drugs

Jiyu Tang
Nan Yang
Shujun Pan
Peiyao Ren
Maosheng Chen
Juan Jin
Qiang He
Yuqun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1331671

2,449 views
5 citations

Retraction

Published on 07 Dec 2023

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

in Pharmacology of Anti-Cancer Drugs

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1337635

1,328 views

Systematic Review

Published on 06 Dec 2023

Comparative efficacy and safety of systemic therapy for advanced hepatocellular carcinoma: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Di Wu
Binyang Jia
Muyuan Jia
Haitao Zhao
Hong Zhao
Jinxue Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1274754

4,311 views
5 citations

Original Research

Published on 06 Dec 2023

Assessment of anticancer properties of cumin seed (Cuminum cyminum) against bone cancer

in Pharmacology of Anti-Cancer Drugs

Rajkuberan Chandrasekaran
Muthukumar Krishnan
Sonu Chacko
Omkar Gawade
Sheik Hasan
John Joseph
Evelin George
Nemat Ali
Abdullah F. AlAsmari
Sandip Patil

Frontiers in Oncology

doi 10.3389/fonc.2023.1322875

6,185 views
10 citations

Mini Review

Published on 27 Nov 2023

The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer

in Pharmacology of Anti-Cancer Drugs

Diwakar D. Balachandran
Lara Bashoura
Ajay Sheshadri
Ellen Manzullo
Saadia A. Faiz

Frontiers in Oncology

doi 10.3389/fonc.2023.1295267

4,767 views
6 citations

Original Research

Published on 16 Nov 2023

Long non-coding RNA PRR7-AS1 promotes osteosarcoma progression via binding RNF2 to transcriptionally suppress MTUS1

in Pharmacology of Anti-Cancer Drugs

Gu Chen-Xi
Xu Jin-Fu
Huang An-Quan
Yu Xiao
Wu Ying-Hui
Li Suo-Yuan
Shen Cong
Zou Tian-Ming
Shen Jun

Frontiers in Oncology

doi 10.3389/fonc.2023.1227789

2,646 views

Original Research

Published on 13 Nov 2023

Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study

in Pharmacology of Anti-Cancer Drugs

Jiaqiang Wang
Fan Zhang
Shuping Dong
Yang Yang
Fangfang Gao
Guancong Liu
Peng Zhang
Xin Wang
Xinhui Du
Zhichao Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1227461

1,452 views

Original Research

Published on 31 Oct 2023

The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia

in Pharmacology of Anti-Cancer Drugs

Lu Wang
Qian Wang
Zhen Xu
Linli Yang
Wuliang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1240972

1,689 views
1 citation

Case Report

Published on 24 Oct 2023

Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidote

in Pharmacology of Anti-Cancer Drugs

Aditya Sharma
Philip Benoit
Frederick Lansigan
David Nierenberg

Frontiers in Oncology

doi 10.3389/fonc.2023.1237178

1,987 views
2 citations

Brief Research Report

Published on 24 Oct 2023

Acute low back pain as infusion-related reaction to monoclonal antibodies

in Pharmacology of Anti-Cancer Drugs

Pawel Majenka
Carmen Loquai
Tilman Schöning
Alexander Enk
Jessica Hassel

Frontiers in Oncology

doi 10.3389/fonc.2023.1161818

6,560 views
2 citations

Original Research

Published on 23 Oct 2023

Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors

in Pharmacology of Anti-Cancer Drugs

Liqiong Xue
Wenbo Tang
Jiuli Zhou
Junli Xue
Qun Li
Xiaoxiao Ge
Fengjuan Lin
Wei Zhao
Ye Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1276009

2,814 views
10 citations